Strengthening Aqsens Health’s board with diagnostics market expertise
We're pleased to welcome Paul Eros to our Board of Directors and announce Pekka Hänninen as our new Chairman. We're deeply grateful to Aaron Michelin for his contributions and look forward to continued collaboration.
Vilhelmiina Juusti Appointed as a COO of Aqsens Health Oy Ltd.
Aqsens Health Oy Ltd., a leading provider of biosensor based analysis, is pleased to announce the appointment of Vilhelmiina Juusti as its new Chief Operating Officer (COO).
Aqsens Health’s 2023 wrap-up
It’s time to wrap-up Aqsens Health’s 2023, a year of major scientific steps and large clinical trial kick-offs!
AQ Lab beta testing completed and the platform is ready for commercial deployment
After a year of development and a few months of final beta testing, AQ Lab is ready to be deployed as a research and development platform for E-TRF and biosensor-based projects.
Paving the way to the world’s largest single market – Interview with Aqsens Health’s Senior Project Manager Zhao Zhao
Zhao took the time to answer a few questions about her role at Aqsens, what she looks forward to when managing impactful projects in China , and what she thinks are the most important success factors when collaborating with Chinese partners.
Aqsens Health’s board of directors strengthened with medtech industry expertise – An interview with Tuomo Pätsi
Aqsens Health is happy to announce that Mr. Tuomo Pätsi has been elected to Aqsens Health’s board of directors at Aqsens Health’s annual general meeting. Mr. Pätsi has over 30 years of experience in the medical industry, and he has led several biotech companies through successful market-entry and commercialization…